Aandeel CENTRALPHL CENTRAL PHARMACEUTICALS LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Central Pharmaceuticals Ltd.

Aandelen

CENTRALPHL

BD0487CPL007

slotkoers Dhaka S.E.
Andere beurzen
 00:00:00 27-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
18,6 BDT +1,09% Intraday-grafiek van Central Pharmaceuticals Ltd. -9,27% -7,92%
11/03 Central Pharmaceuticals Ltd. rapporteert winstresultaten voor het tweede kwartaal en de zes maanden eindigend op 31 december 2023 CI
2023 Central Pharmaceuticals Ltd. rapporteert resultaten voor het volledige jaar dat eindigde op 30 juni 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Central Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023
Central Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022
Central Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2020
Central Pharmaceuticals Ltd. Restates Earnings Results for the Period from January-March 2020 and for the Period from July 2019-March 2020
Central Pharmaceuticals Ltd. Recommends 1% Cash Dividend for the Year Ended on June 30, 2019
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2019
CENTRALPHL Announces Demise of Nashima Akhter, Director on May 18, 2018
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2017
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended September 2017
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2017
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2016
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2016
31,105,000 Ordinary Shares of Central Pharmaceuticals Ltd. are subject to a Lock-Up Agreement Ending on 26-JUN-2016.
16,895,000 Ordinary Shares of Central Pharmaceuticals Ltd. are subject to a Lock-Up Agreement Ending on 26-JUN-2014.
Central Pharmaceuticals Ltd. has completed an IPO in the amount of BDT 140 million.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers CENTRALPHL
  4. Nieuws Central Pharmaceuticals Ltd.
  5. Andere talen